{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:126941",
      "entity_text" : "methotrexate",
      "entity_type" : "simple_chemical"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:11006",
      "entity_text" : "CNS",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "The patient was treated with six cycles of rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) with CNS directed therapy with high-dose intravenous and intrathecal methotrexate.",
  "reading_complete" : "2020-08-03T14:42:15Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T14:41:20Z",
  "trigger" : "directed",
  "evidence" : [ "CNS-directed therapy with high-dose intravenous and intrathecal methotrexate" ],
  "pmc_id" : "5582220",
  "score" : 0
}